No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business
Patients hoping for a new alternative to the blockbuster blood thinner Plavix will have to wait a bit longer for a verdict on a promising candidate.
eisai
Immune-Based Treatments for Brain Cancer Post Impressive Early-Stage Results
Approximately 19,000 individuals in the US are diagnosed with primary brain cancers each year.
mikehavRx.com News Bytes: $DCTH, $TRA, $POT, $SUPG, $ACCP.OB, $AMLN
Delcath’s Percutaneous Hepatic Perfusion (PHP) technology allows physicians to deliver significantly higher doses of existing chemotherapy drugs to the liver without exposing each patient’s entire body to the anti-cancer drugs.
FDA to Review Alternative Dosing Method for Bone Marrow Drug
Most people have never heard of myelodysplastic syndrome (MDS), but approximately 10,000 to 15,000 people in the U.S. are diagnosed with it every year.